Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Pharmacological Reports : PR|September 23, 2022
Crosstalk between neurological, cardiovascular, and lifestyle disorders: insulin and lipoproteins in the lead roleRicha Tyagi, Bhupesh Vaidya, Shyam Sunder Sharma
Basic & Clinical Pharmacology & Toxicology|August 29, 2024
Transient receptor potential channels as an emerging target for the treatment of Alzheimer's disease: Unravelling the potential of pharmacological interventionsNishit Joshi, Bhupesh Vaidya, Shyam Sunder Sharma
ACS Chemical Neuroscience|September 12, 2022
Neuroprotective Potential of HC070, a Potent TRPC5 Channel Inhibitor in Parkinson's Disease Models: A Behavioral and Mechanistic StudyBhupesh Vaidya, Ipsita Roy, Shyam Sunder Sharma
Neurochemistry International|September 6, 2023
BTD: A TRPC5 activator ameliorates mechanical allodynia in diabetic peripheral neuropathic rats by modulating TRPC5-CAMKII-ERK pathwayPratik Adhya, Bhupesh Vaidya, Shyam Sunder Sharma
European Journal of Pharmacology|January 15, 2021
Parkinson's disease in women: Mechanisms underlying sex differencesBhupesh Vaidya, Kritika Dhamija, Priyanka Guru, et al.
Mitochondrion|February 9, 2023
2-Aminoethoxydiphenyl borate ameliorates mitochondrial dysfunctions in MPTP/MPP+ model of Parkinson's diseaseBhupesh Vaidya, Mahesh Polepalli, Shyam Sunder Sharma, et al.
Current Neuropharmacology|June 9, 2021
Neuroprotective Potential of Caffeic Acid Phenethyl Ester (CAPE) in CNS Disorders: Mechanistic and Therapeutic InsightsNamrata Pramod Kulkarni, Bhupesh Vaidya, Acharan S Narula, et al.
Pageof 3